bioAffinity releases case study on CyPath Lung test guiding nodule follow-up imaging

• bioAffinity Technologies released a new clinical case study on CyPath Lung, its noninvasive sputum-based lung cancer diagnostic.
• Results have already been presented in the case study release.
• CyPath Lung delivered a negative result that supported a physician decision to order follow-up imaging instead of proceeding directly to biopsy.
• Subsequent imaging showed the suspicious lung finding had resolved, supporting an inflammatory explanation rather than cancer.
• Management framed CyPath Lung as a decision-support tool that can help defer unnecessary invasive procedures in high-risk patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260414087028) on April 14, 2026, and is solely responsible for the information contained therein.